Search This Blog

Friday, February 29, 2008

RESTASIS QID FOR SLK

Cornea - Abstract: Volume 27(2) February 2008 p 193-195 Topical Cyclosporine A in the Treatment of Superior Limbic Keratoconjunctivitis: A Long-Term Follow-Up.

In this study Cyclosporin .05% was applied topically 4 times a day to patients with superior limbic keratoconjunctivitis. All patients improved remarkably by 2 weeks.

The study concludes:

"Topical CsA 0.05% can be effective in patients with SLK who do not respond to other treatment modalities. It can also be used in the long term to prevent recurrences during treatment and to avoid steroid dependency and the side effects of steroids."

1 comment:

  1. Modeling, for me, isn't about being beautiful but creating something interesting for people to look at and think about. See the link below for more info.


    #interesting
    www.ufgop.org

    ReplyDelete

Leave a Comment or Question: